Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver C...
Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities
About this item
Full title
Author / Creator
Publisher
New Zealand: Dove
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove
Subjects
More information
Scope and Contents
Contents
The development of therapeutics and theranostic nanodrug delivery systems have posed a challenging task for the current researchers due to the requirement of having various nanocarriers and active agents for better therapy, imaging, and controlled release of drugs efficiently in one platform. The conventional liver cancer chemotherapy has many nega...
Alternative Titles
Full title
Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f2eff56a63f54067bbba38e4ef55e4e2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f2eff56a63f54067bbba38e4ef55e4e2
Other Identifiers
ISSN
1178-2013,1176-9114
E-ISSN
1178-2013
DOI
10.2147/IJN.S236927
